Serum gamma-glutamyltransferase activity is increased in patients with calcific aortic valve stenosis

Journal of Heart Valve Disease

Volumn 17, Issue 4, 2008, Pages 371-375

  Bozbas, Huseyin ^a   Yildirir, Aylin ^a   Demir, Ozlem ^a   Cakmak, Abdulkadir ^a   Karacaglar, Emir ^a   Yilmaz, Mustafa ^a   Eroglu, Serpil ^a   Pirat, Bahar ^a   Ozin, Bulent ^a   Muderrisoglu, Haldun ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; LIVER ENZYME;

ADULT; AGE; AGED; AORTA VALVE STENOSIS; ARTERY CALCIFICATION; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENDER; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CALCINOSIS; CASE-CONTROL STUDIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED;

EID: 50249176447     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Nakanishi N, Suzuki K, Tatara K. Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care 2004;27:1427-1432
2. Wannamethee G, Ebrahim S, Shaper AG. - Glutamyltransferase: Determinants and association with mortality from ischernic heart disease and all causes, Am J Epidemiol 1995;142:699-708
3. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: Pathogenesis, disease progression, and treatment strategies. Circulation 2005;111: 3316-3326
4. Otto CM, Kuusisto J, Reichenbach. DD, Gown AM, O'Brien KD. Characterization of the early lesion of degenerative valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994;90:844-853
5. Lee DH, Jacobs DR, Gross M, et al. - Glutamyltransferase is a predictor of incident diabetes and hypertension: The CARDIA Study. Clin Chem 2003;49:1358-1366
6. Perry IJ, Wannamethee SG, Shaper AG. Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. Diabetes Care 1998;21:732-737
7. Paolicchi A, Emdin M, Passino C, et al. Betalipoprotein- and LDL-associated serum gamma-glutamyltransferase in patients with coronary atherosclerosis. Atherosclerosis 2006;186:80-85
8. Turgut O, Yilmaz; A, Yatla K, Karadas F, Yilmaz MB. Gamma-glutamyltransferase is a promising biomarker for cardiovascular risk. Medical Hypotheses 2006;67:1060-1064
9. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease: Cardiovascular Health Study. J Am Coll Cardiol 1997;29: 630-634
10. Bozbas H, Yildirir A, Atar I, et al. Effects of serum levels of novel atherosclerotic risk factors on aortic valve calcification. J Heart Valve Dis 2007;16: 387-393
11. Galante A, Pietroiusti A, Vellini M, et al. C-reactive protein is increased in patients with degenerative aortic valvular stenosis. J Am Coll Cardiol 2001;38:1078-1082
12. Sanchez PL, Santos JL, Kaski JC, et al. Relation of circulating C-reactive protein to progression of aortic valve stenosis. Am J Cardiol 2006;97:90-93
13. Boon A, Cheriex E, Lodder J, Kessels F. Cardiac valve calcification: Characteristics of patients with calcification of the mitral annulus or aortic valve. Heart 1997;78:472-474
14. Adler Y, Vaturi M, Herz I, et al. Nonobstructive aortic valve calcification: A window to significant coronary artery disease. Atherosclerosis 2002;161:193-197
15. Kerner A, Avizohar O, Sella R, et al. Association between elevated liver enzymes and C-reactive protein. Possible hepatic contribution to systemic inflammation in the metabolic syndrome. Arterioscler Thromb Vasc Biol 2005;25:193-197
16. Lee DH, Jacobs DR, Jr. Association between serum gammaglutamyltransf erase and C-reactive protein. Atherosclerosis 2005;178:327-330
17. Schulze PC, Lee RT. Oxidative stress and atherosclerosis. Curr Atheroscler Rep 2005;7:242-248
18. Weiss RM, Ohashi M, Miller JD, Young SG, Heistad DD. Calcific aortic valve stenosis in old hypercholesterolemic mice. Circulation 2006;114:2065-2069
19. Mueller CFH, Laude K, McNally JS, Harrison DG. Redox mechanisms in blood vessels. Arterioscler Thromb Vasc Biol 2005;25:274-278
20. Olsson M, Thyberg J, Nilsson J. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 1999;19:1218-1222
21. Ruttmarm E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: An epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 2005;112:2130-2137